FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:521-522 February 1, 2007 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ahmed, A. R. PubMed Citation

To the Editor: Ahmed et al. (Oct. 26 issue)¹ report a resolution of pemphigus in 9 of 11 patients with refractory disease treated with a combination of 10 infusions of rituximab and 6 of intravenous immune globulin. On the basis of our experience with more than 20 patients with severe pemphigus who were treated with only one cycle of four infusions of rituximab,² we confirm that rituximab has a dramatic effect: more than 90% of our patients had a complete remission, which was maintained after a 24-month follow-up period in two thirds of the patients. We did not treat the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.